Loading organizations...
Loading organizations...
Clinical-stage pharmaceutical company developing skin disease therapeutics.
Brickell Biotech has raised $17.0M across 2 funding rounds.
Brickell Biotech has raised $17.0M in total across 2 funding rounds.
Brickell Biotech has raised $17.0M in total across 2 funding rounds.
Brickell Biotech's investors include Paul Kang, Palisade Capital Management.
Brickell Biotech has raised $17.0M across 2 funding rounds. Most recently, it raised $10.0M Series C in February 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 3, 2015 | $10.0M Series C | ||
| Feb 26, 2013 | $7.0M Series B | Paul Kang | Palisade Capital Management |